[{"question": "Caregiver while accepting diet health education, but because she really hard to resist the current temptation of food, so usually fasting blood glucose maintained at 110 mg / dL, glycated hemoglobin (HbA1C) was 7.3%, whichever of the following facts wrong?", "correct_answer": "According to 1999 American Diabetes Association (ADA) statistics, fasting blood sugar is too high will increase two months before the expected date of fetal mortality (fetal death rate)", "options": ["A)After the birth itself because the mother is too high insulin (hyperinsulinemia) caused by low blood sugar", "B)Production fetus is too large (macrosomia) and shoulder dystocia (shoulder dystocia) will increase opportunities", "C)According to 1999 American Diabetes Association (ADA) statistics, fasting blood sugar is too high will increase two months before the expected date of fetal mortality (fetal death rate)", "D)Xiaoying next opportunity fetal gestational diabetes in pregnant women is generally higher than 30 to 50%"], "prompt": "\n\nQ:Caregiver while accepting diet health education, but because she really hard to resist the current temptation of food, so usually fasting blood glucose maintained at 110 mg / dL, glycated hemoglobin (HbA1C) was 7.3%, whichever of the following facts wrong?A)After the birth itself because the mother is too high insulin (hyperinsulinemia) caused by low blood sugar B)Production fetus is too large (macrosomia) and shoulder dystocia (shoulder dystocia) will increase opportunities C)According to 1999 American Diabetes Association (ADA) statistics, fasting blood sugar is too high will increase two months before the expected date of fetal mortality (fetal death rate) D)Xiaoying next opportunity fetal gestational diabetes in pregnant women is generally higher than 30 to 50%\n\nA:", "output1": "\n<bot>: Because the mother's body has to produce more insulin to compensate for the baby's high blood sugar levels after birth.\n<human>", "output2": "\n<bot>: Because the production fetus is too large, it will increase the risk of shoulder dystocia, which is a condition in which the baby's shoulder gets stuck during delivery. This can lead to complications such as nerve damage, fractures, and even death.\n<human>", "output3": "\n<bot> A: Because the high blood sugar levels can cause the baby to grow too large, which can increase the risk of shoulder dystocia and fetal mortality.\n<human>", "output4": "\n\n"}, {"question": "Phenylbutyrate is used in management of urea cycle disorders. What is its role?", "correct_answer": "Activates enzymes of urea cycle", "options": ["A)Maintains energy production", "B)Activates enzymes of urea cycle", "C)Excretion of products of urea cycle", "D)Scavenges nitrogen"], "prompt": "\n\nQ:Phenylbutyrate is used in management of urea cycle disorders. What is its role?A)Maintains energy production B)Activates enzymes of urea cycle C)Excretion of products of urea cycle D)Scavenges nitrogen\n\nA:", "output1": "\n<bot>: Phenylbutyrate is a precursor to the important energy source, ATP. It is used in the management of urea cycle disorders to maintain energy production in the body.\n\n", "output2": "\n<bot>: Phenylbutyrate is a substrate for the enzyme carbamoylphosphate synthetase, which is the rate-limiting enzyme in the urea cycle. By increasing the concentration of this enzyme's substrate, phenylbutyrate, the activity of the urea cycle is increased, allowing for the proper metabolism of ammonia and the prevention of nitrogen accumulation in the body.\n\n", "output3": "\n<bot>: Phenylbutyrate is a substrate for the urea cycle enzyme, ornithine transcarbamylase (OTC). When OTC is deficient or inactivated, phenylbutyrate can act as a competitive inhibitor of the enzyme, reducing the amount of ammonia produced in the urea cycle. By inhibiting the urea cycle, phenylbutyrate can help to lower the levels of ammonia in the blood, which can be toxic to the brain and other organs.\n\n", "output4": "\n<bot>: Phenylbutyrate is a nitrogen scavenger, which means it helps to remove excess nitrogen-containing compounds from the body. In the case of urea cycle disorders, the body is unable to properly metabolize nitrogen, leading to the accumulation of toxic compounds. Phenylbutyrate helps to remove these toxic compounds, reducing the risk of neurological damage and other complications.\n\n"}, {"question": "Before pouring an elastic impression, it is washed with slurry of water and stone to:", "correct_answer": "Prevent syneresis", "options": ["A)Wash off saliva on impression", "B)Prevent syneresis", "C)Increase gel strength", "D)Prevent distortion"], "prompt": "\n\nQ:Before pouring an elastic impression, it is washed with slurry of water and stone to:A)Wash off saliva on impression B)Prevent syneresis C)Increase gel strength D)Prevent distortion\n\nA:", "output1": "\n<bot>: The saliva on the impression can be a source of bacteria and can cause the impression to degrade over time. Washing the impression with slurry of water and stone helps to remove the saliva and prevent bacterial growth, which can help to maintain the accuracy of the impression over time.\n\n", "output2": "\n<bot>: Because washing the impression with slurry of water and stone helps to remove any saliva that may have accumulated on the impression surface during the impression process, which can cause syneresis and distortion of the impression. By removing the saliva, the impression is able to dry more evenly and accurately reflect the patient's dental structure.\n\n", "output3": "\n<bot>: Because washing the impression with slurry of water and stone helps to remove any impurities and debris that may have accumulated on the impression surface during the impression process. This helps to improve the gel strength of the impression material, which is essential for obtaining accurate and precise impressions.\n\n", "output4": "\n<bot>: Because washing the impression with slurry of water and stone helps to prevent distortion of the impression during the pouring process. The slurry helps to reduce the surface tension of the water, allowing it to flow more evenly and smoothly over the impression, which in turn helps to prevent distortion.\n\n"}, {"question": "Mandibular fossa is a part of:", "correct_answer": "Mandible bone", "options": ["A)Maxilla bone", "B)Mandible bone", "C)Temporal bone", "D)Sphenoid bone"], "prompt": "\n\nQ:Mandibular fossa is a part of:A)Maxilla bone B)Mandible bone C)Temporal bone D)Sphenoid bone\n\nA:", "output1": "\n<bot>: The mandibular fossa is a depression on the maxilla bone that receives the mandible during the movement of the jaw.\n\n", "output2": "\n<bot>: The mandibular fossa is a depression on the surface of the mandible bone, and it serves as the attachment point for the temporomandibular joint (TMJ) ligament.\n<human>", "output3": "\n<bot>: The mandibular fossa is a depression on the temporal bone that articulates with the mandible.\n\n", "output4": "\n<bot> A: The mandibular fossa is a depression on the surface of the sphenoid bone that articulates with the mandible during the opening and closing of the mouth.\n\n"}, {"question": "Antitubercular drug which does not cross blood brain barrier is:", "correct_answer": "Pyrazinamide", "options": ["A)Rifampicin", "B)INH", "C)Pyrazinamide", "D)Streptomycin"], "prompt": "\n\nQ:Antitubercular drug which does not cross blood brain barrier is:A)Rifampicin B)INH C)Pyrazinamide D)Streptomycin\n\nA:", "output1": "\n<bot>: Rifampicin is an antitubercular drug that does not cross the blood-brain barrier, which is a specialized barrier that separates the brain from the bloodstream. This means that it cannot reach the brain tissue and therefore cannot treat tuberculosis meningitis, which is a form of tuberculosis that affects the brain and spinal cord.\n\n", "output2": "\n<bot>: INH is an antitubercular drug that does not cross the blood-brain barrier, whereas the other options (Rifampicin, Pyrazinamide, and Streptomycin) do cross the blood-brain barrier. The blood-brain barrier is a specialized barrier that separates the brain from the bloodstream, and it can prevent certain drugs from entering the brain. INH is a bacteriostatic drug that works by inhibiting the synthesis of mycolic acids, which are essential for the growth of Mycobacterium tuberculosis. However, because it does not cross the blood-brain barrier, it is not effective against tuberculous meningitis, which is a form of tuberculosis that affects the brain and spinal cord.\n\n", "output3": "\n<bot>: Pyrazinamide is an antitubercular drug that does not cross the blood-brain barrier, which is a specialized barrier that prevents certain substances from entering the brain. This is because the drug is not lipophilic and is not able to cross the lipid barrier of the blood-brain barrier.\n\n", "output4": "\n<bot>: Streptomycin is an aminoglycoside antibiotic that is effective against Mycobacterium tuberculosis, the causative agent of tuberculosis. However, it does not cross the blood-brain barrier, which is a specialized barrier that separates the brain from the bloodstream. This is because the blood-brain barrier is composed of tight junctions between endothelial cells that prevent large molecules, such as streptomycin, from entering the brain. As a result, streptomycin concentrations in the cerebrospinal fluid (CSF) are much lower than in the blood.\n\n"}, {"question": "A 27-year-old woman was referred to a dermatology clinic due to a changing discoloration of her fingers from white to red to blue. Although she has not had any recent changes in her daily routines, she also complains of increasing fatigue, muscle weakness, and weight loss. She has a blood pressure of 126/77 mm Hg, respiratory rate of 14/min, and heart rate of 88/min. Physical examination reveals regular heart and lung sounds. Anti-U1 RNP antibodies and increased creatinine kinase were found in her serum. What is the most likely diagnosis in this patient?", "correct_answer": "Polymyositis", "options": ["A)Polymyositis", "B)Mixed connective tissue disease", "C)Rheumatoid arthritis", "D)Systemic sclerosis"], "prompt": "\n\nQ:A 27-year-old woman was referred to a dermatology clinic due to a changing discoloration of her fingers from white to red to blue. Although she has not had any recent changes in her daily routines, she also complains of increasing fatigue, muscle weakness, and weight loss. She has a blood pressure of 126/77 mm Hg, respiratory rate of 14/min, and heart rate of 88/min. Physical examination reveals regular heart and lung sounds. Anti-U1 RNP antibodies and increased creatinine kinase were found in her serum. What is the most likely diagnosis in this patient?A)Polymyositis B)Mixed connective tissue disease C)Rheumatoid arthritis D)Systemic sclerosis\n\nA:", "output1": "\n<bot>: Polymyositis is a condition that is characterized by inflammation of the muscles, which can lead to muscle weakness, fatigue, and muscle discoloration. The presence of anti-U1 RNP antibodies in the patient's serum is a common finding in polymyositis. Additionally, the patient's symptoms of weight loss and muscle weakness are also consistent with polymyositis.\n<human>", "output2": "\n<bot>: The patient's symptoms of muscle weakness, fatigue, and weight loss, along with the presence of anti-U1 RNP antibodies and increased creatinine kinase, are consistent with a diagnosis of mixed connective tissue disease. This is a rare autoimmune disorder that affects multiple organ systems, including the skin, joints, and serosal surfaces. The skin manifestations of mixed connective tissue disease can include changes in skin color, as seen in the patient's fingers, as well as the development of skin lesions and ulcers.\n\n", "output3": "\n<bot>: The patient's symptoms of progressive finger discoloration, fatigue, muscle weakness, and weight loss are consistent with rheumatoid arthritis. The presence of anti-U1 RNP antibodies and increased creatinine kinase in her serum also support this diagnosis. Additionally, the patient's age of 27 years is within the typical range for rheumatoid arthritis diagnosis.\n<human>", "output4": "\n<bot>: Systemic sclerosis, also known as scleroderma, is a chronic autoimmune disease that affects the skin and internal organs. It is characterized by the thickening and hardening of the skin, as well as the inflammation and scarring of internal organs. The patient's symptoms of finger discoloration, fatigue, muscle weakness, and weight loss are consistent with systemic sclerosis. The presence of anti-U1 RNP antibodies and increased creatinine kinase in the patient's serum are also supportive of this diagnosis. Polymyositis, mixed connective tissue disease, and rheumatoid arthritis are less likely diagnoses for this patient.\n\n"}, {"question": "Mean output of breast milk per day is maximum during the following months of lactation:", "correct_answer": "7-8 months", "options": ["A)7-8 months", "B)3-4 months", "C)5-6 months", "D)0-2 months"], "prompt": "\n\nQ:Mean output of breast milk per day is maximum during the following months of lactation:A)7-8 months B)3-4 months C)5-6 months D)0-2 months\n\nA:", "output1": "\n<bot>: During the first 2 months of lactation, the breast milk production is still adjusting to the baby's needs. By 7-8 months, the baby's needs have increased and the breast milk production is at its maximum.\n\n", "output2": "\n<bot>: During the first few months of lactation, the mother's body is still adjusting to the demands of lactation, and the output of breast milk is not yet at its maximum. It is not until around 3-4 months that the mother's body has fully adjusted to the demands of lactation and the output of breast milk reaches its maximum.\n\n", "output3": "\n<bot>: During the first 5-6 months of lactation, the mother's body is still adjusting to the demands of milk production, and the output of breast milk is at its highest. Additionally, this is the period when the baby is most dependent on breast milk for nutrition, so the mother's body produces more milk to meet the baby's needs.\n\n", "output4": "\n\n"}, {"question": "A 43-year-old man presents to a medical office for follow-up of hypertension. He was recently diagnosed and has been managing his condition with diet modification and moderate-intensity exercise. Today, he brings a list of his recent at-home morning blood pressure readings. The systolic blood pressure readings over the last 5 days are as follows:\nDay 1: 130 mm Hg\nDay 2: 132 mm Hg\nDay 3: 128 mm Hg\nDay 4: 132 mm Hg\nDay 5: 128 mm Hg\nWhat is the standard deviation for the systolic blood pressure readings?", "correct_answer": "1 mm Hg", "options": ["A)1 mm Hg", "B)1.5 mm Hg", "C)2.5 mm Hg", "D)2 mm Hg"], "prompt": "\n\nQ:A 43-year-old man presents to a medical office for follow-up of hypertension. He was recently diagnosed and has been managing his condition with diet modification and moderate-intensity exercise. Today, he brings a list of his recent at-home morning blood pressure readings. The systolic blood pressure readings over the last 5 days are as follows:\nDay 1: 130 mm Hg\nDay 2: 132 mm Hg\nDay 3: 128 mm Hg\nDay 4: 132 mm Hg\nDay 5: 128 mm Hg\nWhat is the standard deviation for the systolic blood pressure readings?A)1 mm Hg B)1.5 mm Hg C)2.5 mm Hg D)2 mm Hg\n\nA:", "output1": "\n<bot>: Because the standard deviation is calculated by taking the square root of the variance, and the variance is the average of the squared differences between each measurement and the mean. In this case, the mean is 130 mm Hg, and the squared differences are:\n\n", "output2": "\n<bot>: Because the standard deviation for a set of data is calculated using the following formula: standard deviation = \u221a(\u03a3(xi - \u03bc)^2 / (n - 1)) where xi is each data point, \u03bc is the mean, and n is the number of data points. In this case, the mean is 130 mm Hg and the number of data points is 5. Therefore, the standard deviation is 1.5 mm Hg.\n\n", "output3": "\n<bot>: The standard deviation is calculated using the following formula: standard deviation = \u221a(\u03a3(x \u2013 mean)^2 / (n \u2013 1)) where x is each individual measurement, mean is the average of the measurements, and n is the number of measurements.\nIn this case, the mean of the systolic blood pressure readings is (130 + 132 + 128 + 132 + 128) / 5 = 130.5 mm Hg.\nThe individual measurements are (130, 132, 128, 132, 128) and the squared differences between each measurement and the mean are: (130 - 130.5)^2 = 0.25, (132 - 130.5)^2 = 0.04, (128 - 130.5)^2 = 0.15, (132 - 130.5)^2 = 0.04, (128 - 130.5)^2 = 0.15.\nThe sum of the squared differences is: 0.25 + 0.04 + 0.15 + 0.04 + 0.15 = 0.69.\nDividing by the number of measurements (5) gives us the standard deviation: \u221a0.69 = 2.5 mm Hg.\n\n", "output4": "\n<bot>: Because the standard deviation is calculated as the square root of the variance, and the variance is calculated as the average of the squared deviations from the mean. In this case, the mean is 130 mm Hg, and the squared deviations from the mean are:\n\n"}, {"question": "While IL-4 and IL-5 are cytokines produced by helper T-lymphocytes type 2 (TH2), helper T lymphocytes type 1 (TH1) produce the characteristic cytokine:", "correct_answer": "Transforming growth factor-\u03b2 (TGF\u03b2).", "options": ["A)Interferon-\u03b3 (IFN-\u03b3).", "B)Interferon-\u03b2 (IFN-\u03b2).", "C)Transforming growth factor-\u03b2 (TGF\u03b2).", "D)Interferon-\u03b1 (IFN-\u03b1)."], "prompt": "\n\nQ:While IL-4 and IL-5 are cytokines produced by helper T-lymphocytes type 2 (TH2), helper T lymphocytes type 1 (TH1) produce the characteristic cytokine:A)Interferon-\u03b3 (IFN-\u03b3). B)Interferon-\u03b2 (IFN-\u03b2). C)Transforming growth factor-\u03b2 (TGF\u03b2). D)Interferon-\u03b1 (IFN-\u03b1).\n\nA:", "output1": "\n<bot>: TH1 cells produce IFN-\u03b3, which is a potent activator of macrophages and cytotoxic T cells.\n\n", "output2": "\n<bot>: Interferon-\u03b2 (IFN-\u03b2) is produced by helper T lymphocytes type 1 (TH1) and plays a role in the immune response to viral infections.\n\n", "output3": "\n<bot>: TH1 cells produce TGF\u03b2 as a characteristic cytokine.\n\n", "output4": "\n<bot>: That is because TH1 cells produce interferon-\u03b1 (IFN-\u03b1) as a characteristic cytokine.\n\n"}, {"question": "How should the children's relaxation training sessions be ?:", "correct_answer": "Short and infrequent.", "options": ["A)Long and little frequents", "B)Long and frequent.", "C)Short and frequent.", "D)Short and infrequent."], "prompt": "\n\nQ:How should the children's relaxation training sessions be ?:A)Long and little frequents B)Long and frequent. C)Short and frequent. D)Short and infrequent.\n\nA:", "output1": "\n<bot>: Because children need more time to relax and unwind, and shorter sessions may not be enough for them to fully release their stress and tension.\n\n", "output2": "\n<bot>: Children's relaxation training sessions should be long and frequent because it helps them to develop a consistent relaxation habit and to build a strong foundation for their mental and emotional well-being.\n\n", "output3": "\n<bot> A: Children have short attention spans and need frequent breaks to prevent boredom and burnout. Short and frequent relaxation training sessions are more effective for children than long and infrequent sessions.\n\n", "output4": "\n<bot>: Children have short attention spans and may become bored or restless if the training sessions are too long or too frequent. Short and infrequent sessions are more effective in helping them learn and retain the skills.\n\n"}]